BrainsWay Ltd. (NASDAQ:BWAY – Get Free Report) saw a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 107,500 shares, a growth of 29.8% from the August 31st total of 82,800 shares. Based on an average daily volume of 67,500 shares, the short-interest ratio is […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
BrainsWay (NASDAQ:BWAY – Get Free Report) and Baxter International (NYSE:BAX – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability. Analyst Ratings This is a breakdown of recent ratings […]
BrainsWay (NASDAQ:BWAY – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research note issued on Wednesday, Benzinga reports. They presently have a $12.00 price objective on the stock. HC Wainwright’s price objective suggests a potential upside of 225.20% from the stock’s current price. Separately, Raymond James […]
BrainsWay Ltd. (NASDAQ:BWAY – Get Free Report) saw a large decline in short interest in the month of August. As of August 15th, there was short interest totalling 22,500 shares, a decline of 26.2% from the July 31st total of 30,500 shares. Based on an average daily trading volume, of 63,600 shares, the days-to-cover ratio […]